| PERIOD ENDING | 31-Mar-09 | 31-Mar-08 | 31-Mar-07 | | Total Revenue | 563,613 | 621,568 | 782,431 | | Cost of Revenue | 480,441 | 511,139 | 640,637 | | | Gross Profit | 83,172 | 110,429 | 141,794 | | | Operating Expenses | | Research Development | 18,404 |
-
|
-
| | Selling General and Administrative | 77,875 | 119,142 | 109,861 | | Non Recurring | 1,750 |
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (14,857) | (8,713) | 31,933 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 117 | 632 | 1,139 | | Earnings Before Interest And Taxes | (14,740) | (8,081) | 33,072 | | Interest Expense | 1,015 | 1,066 | 1,026 | | Income Before Tax | (15,755) | (9,147) | 32,046 | | Income Tax Expense | (6,247) | (5,888) | 9,976 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (9,508) | (3,259) | 22,070 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (9,508) | (3,259) | 22,070 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($9,508) | ($3,259) | $22,070 |
|
1.04% Nasdaq 
Income Statement
